MetaCap

Karyopharm Therapeutics Inc. (KPTI)

NASDAQ: KPTIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.6163-0.0287 (-4.44%)

Market open · Delayed 15 min · as of Oct 8, 2:13 PM ET

KPTI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$13.98M
EPS (TTM)
-$14.33
52-week range
0.60 – 10.99
Day range
0.60 – 0.6438
Volume / Avg
473.36K / 1.70M
Beta
—
Next earnings
Nov 2, 2026

52-week range

$0.60$10.99

KPTI stock today

Shares of Karyopharm Therapeutics (KPTI) are trading lower on Oct 8 at $0.6163, a drop of 4.44% or $0.0287 per share, versus the S&P 500's 0.65% decline. At this level, KPTI sits near the bottom of its 52-week range of $0.60 to $10.99: 94.4% below the high, set on Feb 24, 2026 and 2.7% above the low. KPTI is down 91.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 88.8%.

Karyopharm Therapeutics has posted a net loss over the last twelve months (EPS of -$14.33), so its P/E ratio is not meaningful. Karyopharm Therapeutics's next earnings report is expected on Nov 2, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Karyopharm Therapeutics

Company profile
Industry
Biotechnology: Pharmaceutical Preparations
IPO year
2013

Earnings

Earnings history
Next report
Nov 2, 2026
EPS estimate
$-1.15

Karyopharm Therapeutics peers

Health Care sector
KPTI peer companies
CompanyPrice% ChgMarket capCompare
DAREDare Bioscience Inc.0.7556-4.36%$14.86Mvs KPTI
KTTAPasithea Therapeutics Corp.0.4507+1.65%$15.06Mvs KPTI
TVRDTvardi Therapeutics Inc.1.07-2.73%$14.27Mvs KPTI
ALLRAllarity Therapeutics Inc.0.9706-1.35%$15.44Mvs KPTI
HINDVyome Holdings Inc.1.99-2.45%$13.97Mvs KPTI
ACTUActuate Therapeutics Inc.0.6601-8.85%$15.85Mvs KPTI
AEONAEON Biopharma Inc. Class A0.3178+2.10%$15.85Mvs KPTI
BFRIBiofrontera Inc.0.915-2.21%$13.59Mvs KPTI

Indexes, lists and sector

Karyopharm Therapeutics stock FAQ

What is Karyopharm Therapeutics's stock price today?

KPTI last traded at $0.6163 as of Oct 8, 2:13 PM EDT, down 4.44% on the day. Prices are delayed at least 15 minutes.

Does Karyopharm Therapeutics pay a dividend?

No. Karyopharm Therapeutics does not currently pay a regular cash dividend.

When is Karyopharm Therapeutics's next earnings date?

Karyopharm Therapeutics is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $-1.15.

Has KPTI ever split its stock?

Yes. The most recent KPTI stock split was a 1-for-15 split on Feb 26, 2025.

What is the KPTI 52-week high?

The 52-week high for KPTI is $10.99 and the 52-week low is $0.60. The stock is currently 94.4% below its high.

Compare KPTI